Roka Bioscience (ROKA) Reports Q3 Loss of $5.39/Share

November 7, 2016 5:23 PM EST
Get Alerts ROKA Hot Sheet
Trade ROKA Now!
Join SI Premium – FREE

Get daily under-the-radar research with's Stealth Growth Insider Get your 2-Wk Free Trial here.

Roka Bioscience (NASDAQ: ROKA) reported Q3 EPS of ($5.39), versus ($4.91) reported last year. Revenue for the quarter came in at $1.9 million, versus $1.5 million reported last year.

For earnings history and earnings-related data on Roka Bioscience (ROKA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment